Sumatriptan Tablet
Product Images NDC 68071-3755

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68071-3755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3755 9)

Packaging label for Sumatriptan 100 mg U-D Tablets by NuCare Pharmaceuticals, Inc. The label states each tablet contains 140 mg Sumatriptan Succinate USP equivalent to 100 mg Sumatriptan. It includes product number R1301009, NDC 68071-3755-9, and manufacturing information by Aurobindo Pharma Limited, Hyderabad, India. The label carries warnings to keep out of reach of children and storage instructions at controlled temperature 68-77°F.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from initial dose for placebo, 25 mg, 50 mg, and 100 mg doses. The graph indicates increasing probability responses with higher doses and over time up to 240 minutes.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

A line graph depicting the estimated probability of headache remediation or rescue over 24 hours from the initial dose comparing placebo and three dosage levels (25 mg, 50 mg, 100 mg). The y-axis shows probability percentages from 0% to 100%, and the x-axis represents time in hours from 0 to 24. The graph shows increasing remediation probabilities over time for all groups, with placebo having the highest final probability, followed by the 25 mg, 50 mg, and 100 mg doses.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of Sumatriptan Succinate, showing its molecular framework including indole core, sulfonamide group, and succinate moiety as part of the drug's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.